|
||
Deline Dosage |
||
Generic name: Deline 5mg
Dosage form: tablet, film coated; oral solution
The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.
Although an orally disintegrating tablet formulation of Deline may be available in the marketplace, Deline® RediTabs® Tablets are no longer marketed.
Deline Tablets,
Oral Solution, or RediTabs Tablets may be taken without regard to meals. Place Deline (Deline) RediTabs Tablets on the tongue and allow to disintegrate before swallowing. Tablet disintegration occurs rapidly. Administer with or without water. Take tablet immediately after opening the blister.
The age-appropriate dose of Deline
Oral Solution should be administered with a commercially available measuring dropper or syringe that is calibrated to deliver 2 mL and 2.5 mL (½ teaspoon).
The recommended dose of Deline Tablets or Deline Tablets is one 5-mg tablet once daily. The recommended dose of Deline
Oral Solution is 2 teaspoonfuls (5 mg in 10 mL) once daily.
The recommended dose of Deline
Oral Solution is 1 teaspoonful (2.5 mg in 5 mL) once daily. The recommended dose of Deline Tablets is one 2.5-mg tablet once daily.
The recommended dose of Deline
Oral Solution is ½ teaspoonful (1.25 mg in 2.5 mL) once daily.
The recommended dose of Deline
In adult patients with liver or renal impairment, a starting dose of one 5-mg tablet every other day is recommended based on pharmacokinetic data. Dosing recommendation for children with liver or renal impairment cannot be made due to lack of data.
There may be other drugs that can interact with Deline. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.
In controlled clinical studies co-administration of Deline with ketoconazole, erythromycin, or azithromycin resulted in increased plasma concentrations of Deline and 3 hydroxydesloratadine, but there were no clinically relevant changes in the safety profile of Deline.
In controlled clinical studies co-administration of Deline with fluoxetine, a selective serotonin reuptake inhibitor (SSRI), resulted in increased plasma concentrations of Deline and 3 hydroxydesloratadine, but there were no clinically relevant changes in the safety profile of Deline.
In controlled clinical studies co-administration of Deline with cimetidine, a histamine H2-receptor antagonist, resulted in increased plasma concentrations of Deline and 3 hydroxydesloratadine, but there were no clinically relevant changes in the safety profile of Deline.
There is no information to indicate that abuse or dependency occurs with Deline Tablets.
Users | % | ||
---|---|---|---|
Once in a day | 1 | 100.0% |
Users | % | ||
---|---|---|---|
1-5mg | 2 | 66.7% | |
201-500mg | 1 | 33.3% |
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
|